PT Diagnos Laboratorium Utama Tbk (IDX:DGNS)
Indonesia flag Indonesia · Delayed Price · Currency is IDR
304.00
+2.00 (0.66%)
Feb 10, 2026, 9:30 AM WIB

PT Diagnos Laboratorium Utama Tbk Company Description

PT Diagnos Laboratorium Utama Tbk provides health services using laboratories in Indonesia.

The company offers laboratory tests comprising hemostasis, hepatitis, autoimmune and rheumatology, tumor markers, toxicology, lipid, allergies, TORCH, diabetes, electrolytes-blood gases, respiratory tract infection, pathology anatomy, neonatal screening, hematology, body fluids, feces, specific proteins, DNAnswer genomics, kidney function, liver function, immunology, osteoporosis, thyroid, pharmacogenomic, heart, reproduction and fertility, microbiology, drug monitoring, lungs, gastrointestinal, nutrition and heavy metals, anemia and other bacteria; genomics, homecare services; and inspection panel tests.

It also provides doctor consultation; clinic services; corporate health services. PT Diagnos Laboratorium Utama Tbk was founded in 2007 and is headquartered in Jakarta Pusat, Indonesia.

PT Diagnos Laboratorium Utama Tbk
CountryIndonesia
Founded2007
IndustryDiagnostics & Research
SectorHealthcare
Employees111
CEOFergus Richard

Contact Details

Address:
Gedung Graha Anam
Jakarta Pusat, 10350
Indonesia
Phone62 21 3193 1833
Websitediagnos.co.id

Stock Details

Ticker SymbolDGNS
ExchangeIndonesia Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencyIDR
ISIN NumberID1000158702
SIC Code8071

Key Executives

NamePosition
Fergus RichardPresident and Director
Antony SubagiaOperational Director
Martinus Eliatulo ZegaGM of Sales and Independent Commissioner
Maurina DwiyanthiHead of Internal Audit Unit and Manager of SPI
Fanfan RiksaniCorporate Secretary
Stefanus IvanlyCorporate Secretary